Inso Biosciences

Inso Bio, formerly known as Tico Bio, is an early-stage biotechnology startup originating from Cornell University. The company is dedicated to revolutionizing biological sample preparation through innovative platform technologies. Inso Bio's mission is to make genomics more accessible by developing unique tools for biological applications. Their primary focus is on utilizing patented microfluidic technology to enhance the processing of cellular samples. This technology has potential applications in long-read DNA sequencing, multi-omic analysis (which involves studying various biological molecules like DNA, RNA, proteins, and metabolites), and pathogen isolation.

Inso Bio serves a diverse range of clients, including research institutions, healthcare providers, and biotechnology companies. These clients are involved in genomics, molecular biology, and infectious disease research. The startup operates within the biotechnology market, specifically targeting the niche of biological sample preparation.

The business model of Inso Bio revolves around the development and commercialization of its proprietary microfluidic technology. The company generates revenue by selling its advanced sample preparation tools to research labs and biotech firms. Additionally, Inso Bio may explore licensing agreements and partnerships with larger companies in the biotech and healthcare sectors to further monetize its technology.

Inso Bio is currently in the development phase, working on advancing its technology and building its first product. The company is housed within the Cornell University McGovern Center Incubator for Life Science Venture Development, which provides a supportive environment for early-stage biotech startups. Inso Bio has received funding from prestigious institutions such as the U.S. National Science Foundation (NSF) and the U.S. National Institutes of Health (NIH), which underscores the potential and credibility of its innovative solutions.

Keywords: biotechnology, microfluidic technology, genomics, sample preparation, DNA sequencing, multi-omic analysis, pathogen isolation, Cornell University, research tools, early-stage startup.